FDC [FDC] vs Procter & Gamble [PGHL] Detailed Stock Comparison
FDC
NSE
Loading...
Procter & Gamble
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: FDC wins in 7 metrics, Procter & Gamble wins in 13 metrics, with 0 ties. Procter & Gamble appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | FDC | Procter & Gamble | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 28.89 | 57.14 | FDC |
| Price-to-Book Ratio | 3.40 | 19.56 | FDC |
| Debt-to-Equity Ratio | 0.93 | 0.01 | Procter & Gamble |
| PEG Ratio | 15.09 | -4.58 | Procter & Gamble |
| EV/EBITDA | 22.76 | 31.97 | FDC |
| Profit Margin (TTM) | 12.70% | 20.62% | Procter & Gamble |
| Operating Margin (TTM) | 19.35% | 25.06% | Procter & Gamble |
| EBITDA Margin (TTM) | 19.35% | 25.06% | Procter & Gamble |
| Return on Equity | 11.70% | 37.41% | Procter & Gamble |
| Return on Assets (TTM) | 9.83% | 25.30% | Procter & Gamble |
| Free Cash Flow (TTM) | $2.21B | $2.07B | FDC |
| Dividend Yield | 1.07% | 2.35% | Procter & Gamble |
| 1-Year Return | -10.70% | 21.68% | Procter & Gamble |
| Price-to-Sales Ratio (TTM) | 3.67 | 8.64 | FDC |
| Enterprise Value | $72.89B | $103.00B | Procter & Gamble |
| EV/Revenue Ratio | 3.44 | 9.12 | FDC |
| Gross Profit Margin (TTM) | 67.73% | 72.25% | Procter & Gamble |
| Revenue per Share (TTM) | $130 | $734 | Procter & Gamble |
| Earnings per Share (Diluted) | $16.53 | $111.00 | Procter & Gamble |
| Beta (Stock Volatility) | -0.06 | 0.43 | FDC |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
FDC vs Procter & Gamble Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| FDC | -0.33% | -1.02% | -1.60% | 6.34% | 17.90% | -6.24% |
| Procter & Gamble | 1.82% | -0.29% | 8.24% | 20.33% | 20.19% | 20.61% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| FDC | -10.70% | 81.83% | 45.63% | 146.44% | 356.38% | 792.36% |
| Procter & Gamble | 21.68% | 43.85% | 33.86% | 666.19% | 768.70% | 1,273.25% |
Performance & Financial Health Analysis: FDC vs Procter & Gamble
| Metric | FDC | PGHL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹77.76B | ₹105.29B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 91,731 | 43,440 |
| 90 Day Avg. Volume | 97,133 | 22,723 |
| Last Close | ₹477.60 | ₹6,295.00 |
| 52 Week Range | ₹366.25 - ₹658.85 | ₹4,863.00 - ₹6,500.00 |
| % from 52W High | -27.51% | -3.15% |
| All-Time High | ₹658.85 (Sep 09, 2024) | ₹7,500.00 (Feb 08, 2021) |
| % from All-Time High | -27.51% | -16.07% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.02% | 0.19% |
| Quarterly Earnings Growth | 0.02% | 2.94% |
| Financial Health | ||
| Profit Margin (TTM) | 0.13% | 0.21% |
| Operating Margin (TTM) | 0.19% | 0.25% |
| Return on Equity (TTM) | 0.12% | 0.37% |
| Debt to Equity (MRQ) | 0.93 | 0.01 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹140.39 | ₹324.25 |
| Cash per Share (MRQ) | ₹32.99 | N/A |
| Operating Cash Flow (TTM) | ₹3.54B | ₹3.20B |
| Levered Free Cash Flow (TTM) | ₹2.67B | ₹2.01B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.07% | 2.35% |
| Last 12-Month Dividend | ₹5.00 | ₹140.00 |
Valuation & Enterprise Metrics Analysis: FDC vs Procter & Gamble
| Metric | FDC | PGHL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 28.89 | 57.14 |
| Forward P/E | 20.50 | N/A |
| PEG Ratio | 15.09 | -4.58 |
| Price to Sales (TTM) | 3.67 | 8.64 |
| Price to Book (MRQ) | 3.40 | 19.56 |
| Market Capitalization | ||
| Market Capitalization | ₹77.76B | ₹105.29B |
| Enterprise Value | ₹72.89B | ₹103.00B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.44 | 9.12 |
| Enterprise to EBITDA | 22.76 | 31.97 |
| Risk & Other Metrics | ||
| Beta | -0.06 | 0.43 |
| Book Value per Share (MRQ) | ₹140.39 | ₹324.25 |
Financial Statements Comparison: FDC vs Procter & Gamble
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | FDC | PGHL |
|---|---|---|
| Revenue/Sales | ₹4.92B | ₹3.39B |
| Cost of Goods Sold | ₹1.61B | ₹939.90M |
| Gross Profit | ₹3.31B | ₹2.45B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹403.92M | ₹849.00M |
| EBITDA | ₹700.63M | ₹943.70M |
| Pre-Tax Income | ₹533.08M | ₹888.10M |
| Income Tax | ₹146.37M | ₹226.30M |
| Net Income (Profit) | ₹386.71M | ₹661.80M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | FDC | PGHL |
|---|---|---|
| Cash & Equivalents | ₹514.72M | ₹1.82B |
| Total Current Assets | ₹10.89B | ₹5.26B |
| Total Current Liabilities | ₹3.62B | ₹2.15B |
| Long-Term Debt | ₹121.17M | ₹48.10M |
| Total Shareholders Equity | ₹22.81B | ₹5.37B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹8.48B | ₹1.11B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | FDC | PGHL |
|---|---|---|
| Operating Cash Flow | N/A | ₹711.00M |
| Capital Expenditures | N/A | ₹-32.30M |
| Free Cash Flow | N/A | ₹459.90M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | FDC | PGHL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 91,731 | 43,440 |
| Average Daily Volume (90 Day) | 97,133 | 22,723 |
| Shares Outstanding | 162.81M | 16.60M |
| Float Shares | 84.47M | 7.93M |
| % Held by Insiders | 0.70% | 0.52% |
| % Held by Institutions | 0.08% | 0.16% |
Dividend Analysis & Yield Comparison: FDC vs Procter & Gamble
| Metric | FDC | PGHL |
|---|---|---|
| Last 12-Month Dividend | ₹5.00 | ₹140.00 |
| Last 12-Month Dividend Yield | 1.07% | 2.35% |
| 3-Year Avg Annual Dividend | ₹1.67 | ₹98.83 |
| 3-Year Avg Dividend Yield | 0.98% | 0.99% |
| 3-Year Total Dividends | ₹5.00 | ₹296.50 |
| Ex-Dividend Date | Nov 22, 2024 | Feb 21, 2025 |